Naoto Ueno
Naoto T Ueno (born March 29, 1964) is a Professor of Medicine at The University of Texas MD Anderson Cancer Center; his research is in the area of inflammatory breast cancer and the molecular mechanism of metastasis and tumorigenicity. Ueno is also affiliated with the Keio University as a visiting professor.
He is breast medical oncologist who specialized in inflammatory breast cancer, triple negative breast cancer, and metastatic breast cancer. He is best known for his preclinical development of E1A gene therapy and multiple preclinical development which led to novel clinical trials related to inflammatory breast cancer and triple negative breast cancer.
He is well known for both his p*ion and commitment in cancer research and for comp*ion to take care of advanced breast cancer. He is currently studying cancer metastasis, MAPK/EGFR pathways, and cancer microenviroment. He is the executive director of the Morgan Welch Inflammatory Breast Cancer Program and Clinic and Section Chief of the Translational Breast Cancer Research at Department of Breast Medical Oncology.
He has been invited to talk about patient empowerment in Tokyo TEDx in 2011.
Awards
- 1995-1996 Clinical Fellow Research Award, MD Anderson Cancer Center
- 1996 Cancer Research Achievement Award, MD Anderson Cancer Center
- 1996 Houston Endowment, Jesse H. Jones Fellowship in Cancer Education
- 1996 Outstanding Achievement in Cancer Research Award, Pharmacia and Upjohn
- 1998 American *ociation Cancer Research-Glaxo Wellcome Oncology Clinical Research Scholar Award for Promising Translation or Clinical Research, Glaxo Wellcome
- 2008 6th Robert M. Chamberlain Distinguished Mentor Award Nomination (Top Three Finalist), MD Anderson
- 2011 Amgen Basic Research Award, 2nd Prize for Mentoring, MDACC
- 2013 Regent's Outstanding Teaching Award, University of Texas
- 2013 Bradley Stuart Beller Special Merit ASCO Merit Award for Hiroko Masusda, MD, PhD (Mentee)
- 2018 Rune for the Cure Foundation. Unknown Hero Award.